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Abstract
Hepatitis A virus (HAV), the prototype of genus Hepatovirus, has several unique biological characteristics that distinguish it
from other members of the Picornaviridae family. Among these, the need for an intact eIF4G factor for the initiation of
translation results in an inability to shut down host protein synthesis by a mechanism similar to that of other picornaviruses.
Consequently, HAV must inefficiently compete for the cellular translational machinery and this may explain its poor growth
in cell culture. In this context of virus/cell competition, HAV has strategically adopted a naturally highly deoptimized codon
usage with respect to that of its cellular host. With the aim to optimize its codon usage the virus was adapted to propagate
in cells with impaired protein synthesis, in order to make tRNA pools more available for the virus. A significant loss of fitness
was the immediate response to the adaptation process that was, however, later on recovered and more associated to a re-
deoptimization rather than to an optimization of the codon usage specifically in the capsid coding region. These results
exclude translation selection and instead suggest fine-tuning translation kinetics selection as the underlying mechanism of
the codon usage bias in this specific genome region. Additionally, the results provide clear evidence of the Red Queen
dynamics of evolution since the virus has very much evolved to re-adapt its codon usage to the environmental cellular
changing conditions in order to recover the original fitness.
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Introduction
Non-random usage of synonymous codons is a widespread
phenomenon observed in genomes from many species in all
domains of life and it has been proposed that each genome has a
specific codon usage signature that reflects particular evolutionary
forces acting within that genome [1,2]. Such codon usage biases
may result from mutational biases, from natural selection acting on
silentchanges inthegenomesorboth.Selectiononcodon usage due
to codon adaptation to the tRNA pool was clearly demonstrated in
Escherichia coli [3]. Later on, this premise was also confirmed in
eukaryotic organisms including vertebrates [4–8], supporting the
hypothesis of translational selection as a driving evolutionary force.
However, this hypothesis is not extensive to all organisms and in
humans there is no clear evidence of translation selection as the
single driving force of codon bias [9]. In this latter case many
different reasons have been identified to explain codon bias:
isochoric structure of GC content [10], mRNA secondary structure
selection [11], exonic splicing enhancer selection [12,13], and last
but not least translation selection [14,15]. Additionally, there is also
evidence of pressure on codon usage for the control of translation
kinetics rather than for the efficiency and accuracy of translation
[16,17]. Translation kinetics control is exerted through the use of
common and rare codons, which affect the rate of ribosome traffic
on the mRNA due to the longer time required for incorporating
those tRNAs pairing with rare codons into the ribosome A-site. The
right combination of codons allows a regulated ribosome traffic rate
that temporally separates protein folding events, ensuring ‘‘benefi-
cial’’ and avoiding ‘‘unwanted’’ interactions within the growing
peptide[18].Thiskind ofselection, knownasfine-tuning translation
selection, differs from translation selection in that preferred codons
are not always advantageous if the optimal folding requires a slow
translation.
A statistical model for translational selection measure was
developed based on fully sequenced genomes from archaea,
bacteria and eukarya [19]. This model shows that small genome
size allows higher action of translation selection, whilst lack of
tRNA gene redundancy accounts for the absence of translationally
selected codons. Bearing in mind this model, it seems reasonable
that translation selection might play a key role on eukaryotic
viruses, which present tiny genomes and have huge numbers of
tRNA genes available from their hosts. Certainly codon bias has
been observed in several viruses, however, its driving force has
only been studied in particular cases, such as Epstein-Barr Virus
[20] and papillomavirus [21] among DNA viruses, and poliovirus
(PV) [22] and hepatitis A virus (HAV) [23] among RNA viruses.
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of the codon bias of those genes expressed during the productive
phase in the DNA viruses, the mechanism in the RNA viruses is
more variable. The codon usage bias in the capsid of PV, which
presents a highly optimized codon usage with that of its host, has
been proposed to be mostly the result of an additional step on
translation selection, i.e., the effect of certain codon-pair
combinations on the rate of translation [24] rather than only the
tRNA availability. This may be due to the fact that translational
step times are influenced by the compatibilities of adjacent tRNA
isoacceptor molecules on the surface of a translating ribosome
[25]. Alternatively, it has also been proposed the GC dinucleotide
content as the cause of codon bias in the capsid of PV [22].
However, HAV is clearly the exception to the rule. HAV
presents a highly biased codon usage and mostly opposed to that of
the host cell [23]. Despite lacking mechanisms of inducing cellular
shutoff [26,27] and having a very inefficient IRES [28], HAV is
able to synthesize its proteins by adapting their codon usage to
those less commonly used cellular tRNAs, resulting in a low
replication rate [29]. With that naturally deoptimized codon usage
the role of translation selection in shaping the HAV codon bias
does not seem very obvious.
HAV is the type species of the genus Hepatovirus within the
family Picornaviridae, existing as a single serotype. The occurrence
of highly conserved clusters of rare codons in the HAV capsid-
coding region has been related to the low antigenic variability
[30], since mutations in these clusters are negatively selected even
in the presence of immune pressure. Thus, a certain beneficial role
of these rare codons is envisaged. Altogether, it can be concluded
that codon usage plays a key role in HAV replication and
evolution.
To elucidate the underlying mechanisms of the naturally
deoptimized codon usage of HAV, a system to cultivate the virus
in a cellular environment with a modified tRNA pool was
developed. This was achieved using actinomycin D (AMD), which
specifically inhibits the DNA-dependent RNA polymerases with
no effect on the RNA-dependent RNA polymerases [31]. In these
conditions of cellular transcription inhibition and hence cellular
protein synthesis shut-off, the tRNA pool available for the virus is
expected to increase and consequently the virus codon usage may
readapt to the new conditions. HAV, being an RNA virus,
replicates as a complex and dynamic mutant spectrum or swarm of
non identical but very closely related individuals, called viral
quasispecies [32,33]. The population landscape of these molecular
spectra allows a more broad analysis of all ongoing mutations
necessary for the study of codon usage adaptation. The response
regarding the viral replicative fitness and codon usage assessed
during the adaptation to AMD exclude translation selection and
instead suggest fine-tuning translation kinetics selection as the
underlying mechanism of the codon usage bias in the capsid
coding region.
Results
Viral replication in conditions of cellular shut-off: fitness
loss and fitness recovery
Actinomycin D (AMD) treatment induced a clear dose-
dependent inhibition of gene expression of FRhk-4 cells with a
total cytoplasmic RNA reduction of around 40% and over 80% at
concentrations of 0.05 mg/ml and 0.2 mg/ml, respectively (Fig. 1).
Additionally, the expression of the housekeeping genes HPRT-I
and GAPDH was also significantly reduced by 62% and 80%,
respectively, at 0.05 mg/ml of AMD and 97% and 94%,
respectively, at 0.2 mg/ml of AMD. In contrast, neither the
cellular RNA abundance nor the housekeeping gene expression
was significantly affected as a consequence of HAV replication.
The AMD-induced cellular shut-off resulted in a cell viability of
75% and 0.25% with 0.05 mg/ml and 0.2 mg/ml, respectively, at 7
days post-treatment; of around 100% and 10%, respectively, at 4
Figure 1. Abundance (percent) of total cytoplasmic RNA and
mRNA from two house-keeping genes (GAPDH and HPRT-I) in
uninfected FRhK-4 cell monolayers growing in the absence of
AMD, in the presence of 0.05 mg/ml and 0.2 mg/ml of AMD, and
in HAV-infected cells in the absence of the drug.
doi:10.1371/journal.ppat.1000797.g001
Author Summary
Each organism has a specific codon usage signature.
Translational selection i.e., selection for the codon
adaptation to the tRNA pools, is one of the driving forces
of codon bias. In the virus world, this implies an
adjustment of the virus codon usage to that of the host
cell. Hepatitis A virus appears as an exception to the rule,
with a highly deoptimized codon usage, suggesting that
translational selection is not the underlying mechanism of
its codon bias. However, since the virus lacks a mechanism
of cellular protein synthesis inhibition, the deoptimized
codon usage may be envisaged as a hawk (cell) and dove
(hepatitis A virus) competition strategy for tRNAs and
translational selection as well. To confirm this possibility,
we artificially induced cell protein synthesis shut-off, thus
increasing the tRNA pool availability for the virus, and we
took advantage of the quasispecies dynamics to elucidate
changes in its codon usage. Virus adaptation to the drug
results in a re-deoptimization of codon usage in the capsid
region, suggesting a requirement of a slow translation rate,
i.e., a translation kinetic selection, instead of a translational
selection associated with an optimization of the codon
usage. Translation kinetics control is based on the right
combination of codons (common and rare) that allows a
regulated ribosome traffic rate ensuring the proper protein
folding. Capsid folding is critical for a virus transmitted
through the fecal-oral route with long extracorporeal
periods.
Translation Kinetics Selection in the HAV Capsid
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post-treatment.
The effect of AMD-induced cellular shut-off on viral fitness was
analyzed in an attempt to reproduce what occurs in other
picornaviruses such as poliovirus. In the presence of 0.05 mg/ml of
AMD, and during the early passages, HAV showed a loss in fitness
(figured as virus production per cell), and at 0.2 mg/ml of AMD
concentration the virus population was completely extinct (Fig. 2).
In contrast PV, which induces cellular shut-off by itself and that
has an optimized codon usage, readily showed a fitness gain in the
presence of 0.2 mg/ml of AMD (Fig. 3).
To find out whether HAV could recover its fitness through a
change of its codon usage, further passages in the presence of the
drug were performed (Fig. 4). Replication in the presence of
0.05 mg/ml of AMD (lineage 1) was examined for over 150
passages (Fig. 4B) using as baseline control the viral replication in
the absence of AMD (lineage 0) (Fig. 4A). As aforementioned, after
few passages in the presence of the drug, viral production was
severely decreased, with peaks of less than 1 TCID50 per cell
(Fig. 4B). However, thereafter the viral population progressively
adapted to AMD, giving rise again to viral progenies quantitatively
equivalent to those of the population growing in absence of the
drug. Additionally, after 65 passages the AMD-pre-adapted
population was submitted to an increased concentration of the
drug (0.2 mg/ml) (lineage 2), and again a decrease followed by a
clear recovery in the viral production was observed (Fig. 4C). To
further test the fitness of the populations adapted to the different
AMD concentrations, viral populations were again submitted to
the original conditions. For instance, once adapted to 0.05 mg/ml
(lineage 1), the virus population was brought back to grow in the
absence of the drug (lineage 3) (Fig. 4D). The immediate response
was again an abrupt decrease in the viral progeny that, however,
was very rapidly recovered. Similarly, when the 0.2 mg/ml AMD-
adapted population (lineage 2) was brought back to the original
0.05 mg/ml concentration (lineage 4), the same pattern of behavior
of an initial loss in fitness followed by a fitness recovery was
observed (Fig. 4E). Nevertheless, the analysis of the viral
production of the first 20 passages of the different adaptive
processes showed that the kinetics of adaptation was faster during
the re-adaptation to the original conditions than during the first
adaptation to the different AMD concentrations, with significantly
(p,0.05) different slopes of the regression lines (Fig. S1).
Codon usage in depleted vs abundant tRNA pools: codon
usage adapts to tRNA concentration
The Relative Codon Deoptimization Index (RCDI) [34]
measures the adaptation of a virus codon usage to that of its host.
Figure 2. HAV yield as a measure of viral fitness in the absence
and presence of AMD. A. 0.0 mg/ml of AMD. B. 0.05 mg/ml of AMD. C.
0.2 mg/ml of AMD. Dotted lines depict maximum and minimum virus
yields per cell.
doi:10.1371/journal.ppat.1000797.g002
Figure 3. PV yield as a measure of viral fitness in the absence
and presence of AMD. A. 0.0 mg/ml of AMD. B. 0.05 mg/ml of AMD. C.
0.2 mg/ml of AMD. Dotted lines depict maximum and minimum virus
yields per cell.
doi:10.1371/journal.ppat.1000797.g003
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usage, while the higher the value the higher the deviation from the
host. Thus, a value of around 1.70 denotes that HAV posses a
highly deoptimized codon usage compared to other picornaviruses
whose RCDI range from 1.14 to 1.39 (Table S1). Since HAV is
not able to induce cellular shut-off [26,27] (Fig. 1), the
optimization of the viral codon usage to that of the host cell
could lead to an unfair competition for tRNA resources. In
contrast replication in the presence of AMD, which clearly inhibits
cellular expression, may represent an environment with increased
available tRNA pools. Hence, an analysis to test the adaptation to
tRNA pools was performed by studying the mutant spectrum of
each adapting lineage at different passages and determining the
codon usage in each of these spectra. Particularly passages P4, P5,
P20, P36, P38, P41, P44, P65 and P85 of lineage 1 and P20 and
P38 of lineage 2 (P20’ and P38’ in Fig. 5) were analyzed.
Additionally, the mutant spectrum of lineage 3 was also analyzed
at P21. In each case the quasispecies distribution of lineage 0 was
used as baseline control of the molecular evolution. Three
genomic regions were analyzed: two fragments from the structural
polyprotein coding region (a VP3 fragment and a VP1 fragment)
and a fragment from the polymerase coding region.
Any mutation induces a codon change and the newly generated
codons were classified as being similarly frequent (within a 10%
range), less frequent (below 10%) or more frequent (above 10%)
than the original ones with respect to the cell host codon usage, as
an indication of the adaptation to the cellular tRNA pool. A
different pattern of molecular evolution was observed depending
on the genomic region analyzed. The structural polyprotein
coding regions of the AMD-adapting populations showed a
tendency to progressively accumulate mutations that induced the
use of codons less common than the original ones (Fig. 5B), with an
average of 75% of mutations in this direction in both the last
passages of lineage 1 and all passages of lineage 2. On the
contrary, the new generated codons in lineage 0 were mostly
similar to the original ones (Fig. 5A). Particularly, 54% of the
mutations gave rise to codons of the same frequency, 31% to less
frequent codons and 15% to more common codons. Quite the
opposite, in the polymerase region a complete dominance of
mutations inducing changes in the level of frequency (almost
equally in both directions less and more frequent) of the new
codons was observed in all lineages (Fig. 5C and 5D).
Assuming a parallel behavior between the particular capsid
coding regions analyzed and the complete capsid coding region,
and applying the Poisson distribution model, it may be postulated
that while at P5, during the adaptation to 0.05 mg/ml of AMD,
around 50% of the genomes would present only 1 mutation
inducing the generation of a less common codon, from P38 and
further 50% of the genomes would harbor at least 5 of such
mutations. In other words, the percentage of genomes with zero
mutations of this kind would progress from 20% at P5 to 0.20% at
P85.
Since competition is established for the tRNA resources, a
refined analysis involving the study of anticodon usage was
performed by inferring theoretical anticodon usage tables from the
actual codon usage tables which were built from the analysis of 50
molecular clones representative of a mutant spectrum (Table S4, A
and S5, A), but introducing the codon-anticodon multiple pairing
effects corrected by the codon-anticodon coupling efficiency [19].
Two codon usage tables were made for each viral population at
each analyzed passage, one using the mutant spectra in the VP1-
and VP3-region analyzed (Table S4, A) and a second one using
the mutant spectrum of the 3D-region analyzed (Table S5, A).
Likewise, two anticodon usage tables were built: one for the capsid
region (Table S4, B) and another for the polymerase region (Table
S5, B). The relative anticodon usage for each amino acid family
was also figured (Tables S4, C and S5, C). Additionally, an
anticodon usage table for the host cell was also built and a relative
anticodon usage determined by arbitrarily giving to the most
abundant anticodon in each amino acid family a value of 100%
and the remaining anticodons were percentualy referred to this
most abundant one. Anticodons were then sorted in three groups
Figure 4. HAV adaptation to different AMD conditions. A. As a control, the virus population was grown in the absence of the drug (0.0 mg/ml
of AMD; lineage 0). B. Adaptation of the virus population to 0.05 mg/ml of AMD (0.05 mg/ml of AMD; lineage 1). C. At passage 65, lineage 1 population
was transferred to 0.2 mg/ml of AMD (0.05 mg/ml of AMD R0.2 mg/ml AMD; lineage 2). D. At passage 85, lineage 1 population was transferred back to
0.0 mg/ml of AMD (0.05 mg/ml of AMD R0.0 mg/ml of AMD; lineage 3). E. At passage 65, lineage 2 population was transferred back to 0.05 mg/ml of
AMD (0.2 mg/ml of AMD R0.05 mg/ml of AMD; lineage 4). Dotted lines depict maximum and minimum virus yields per cell. Arrows depict changes in
AMD conditions.
doi:10.1371/journal.ppat.1000797.g004
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the cell at a proportion below 20% (,20%), anticodons used by
the cell at a proportion between 20% and 60% (20%–60%) and
anticodons used by the cell at a proportion above 60% (.60%).
The viral relative anticodon usage variation of each population in
each passage, with respect to the initial passage in the absence of
the drug, was calculated (Table S4, D and Table S5, D). Increases
or decreases (in percentage) of use of the anticodons belonging to
the above mentioned groups were analyzed and the mean
variation figured (Fig. 6). Lineage 0 showed no major statistical
(p,0.05) variation of the anticodon use, with the exception of the
anticodon group ,20% in the capsid region at P41, P44 and P65
which decreased (Fig. 6). In contrast, lineage 1 showed a significant
(p,0.05) and consistent tendency, in the capsid region, to decrease
the anticodon group .60% and increase the anticodon group
20%–60% (Fig. 6). This tendency was further confirmed with
lineage 2 at P20 and P38 (Fig. 7). Such a tendency was not
observed in the polymerase region (Fig. 6). Five anticodons (Ile:
uag, uai; Thr: ugg; Val: cau, cac) among the .60% group were
responsible for the decrease of the whole group, being their
decrease at P65 of lineage 1 of 25.6%62.5%. Further on this
group decreased from P20 to P38 of lineage 2 from 27.4%63.2%
to 29.5%67.3% (Fig. 7). All these variations were significantly
(p,0.05) different from the values shown by the same anticodons
in lineage 0. On the other sense, the variation of the six anticodons
(Arg: ucc; Ile: uaa, uau; Val: cag, cai, caa) of the 20%–60% group
responsible of the increase of the whole group was also significantly
(p,0.05) different from that of lineage 0 and of 5.4%64.0% (P65
of lineage 1), 8.6%65.5% (P20 of lineage 2) and 9.6%64.5% (P38
of lineage 2) (Fig. 7). Interestingly, when lineage 1 was returned to
the original growing conditions of absence of AMD (lineage 3) for
21 passages (P21R), the anticodon groups .60% and 20%–60%
increased and decreased, respectively. However, although the five
specific anticodons of the .60% group and the six specific
anticodons of the 20%–60% group increased from 26.3%63.5%
to 21.1%64.8% and decreased from 6.9%63.9% to
3.5%62.9%, respectively, these variations were not statistically
significant. However, six additional anticodons belonging to the
.60% group (Ala:cgg, cgi; Glu:cuc; Gly:ccc; His:gug; Pro:ggu) did
significantly (p,0.05) increase an average of 7.8%66.5% in
comparison with the original lineage 1 (P0R) and four more from
the 20%–60% group (Ala:cgc; Gly:cca; His:guc; Ser:ucg) signifi-
cantly (p,0.05) decreased an average of 26.30%61.7% (Fig. S2).
To confirm that the observations made with the molecular
quasispecies analysis of the three specific regions may be inferred
to the whole genome, consensus sequences at P127 of lineages 0
(absence of AMD) and 1 (presence of 0.05 mg/ml of AMD), and at
P62 of lineage 2 (presence of 0.2 mg/ml of AMD) were obtained.
Nine mutations characterized lineage 1. Three of them were
located in the capsid region (m=1.3610
23) and 6 at the non-
structural proteins region (NSP) (m=1.4610
23). Lineage 2 showed
16 mutations, one at the 59 non coding region (m=1.4610
23), 8 in
the capsid region (m=3.4610
23) and 7 at the NSP region
(m=1.6610
23). Most of the mutations occurring in the capsid
region (63%) induced a change to a less frequent codon, as also
occurred in the mutant spectra (75%), while at the NSP region
they mainly induced the change to a more frequent or similar one
(57% and 29%, respectively). Furthermore, the anticodon analysis
Figure 5. Relative proportion (percentage) of the new generated codons detected during the process of HAV adaptation to AMD.
These codons were sorted as being similarly frequent (black fill), less frequent (gray fill) or more frequent (blue fill) than the original ones with respect
to the cell host codon usage. A. Codon usage variation in the capsid region in the absence of AMD (lineage 0). B. Codon usage variation in the capsid
region in the presence of 0.05 mg/ml of AMD (lineage 1) from passage 4 to passage 85, and in the presence of 0.2 mg/ml of AMD (lineage 2) from
passage 20 (P20’) to passage 38 (P38’). C. Codon usage variation in the polymerase region in the absence of AMD (lineage 0). D. Codon usage
variation in the polymerase region in the presence of 0.05 mg/ml of AMD (lineage 1) from passage 4 to passage 85, and in the presence of 0.2 mg/ml
of AMD (lineage 2) from passage 20 (P20’) to passage 38 (P38’).
doi:10.1371/journal.ppat.1000797.g005
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the anticodon group of .60% was observed and the average
variation of the five main anticodons (Ile: uag; Leu: gau; Phe: aag;
Val: cau, cac) responsible for the change of the whole group in
lineage 1 was 22.08% and the variation of the eight main
anticodons (Ile: uag; Leu: gau; Phe: aag; Pro: ggg, ggi; Tyr: aug;
Figure 6. HAV anticodon usage variation in the capsid and polymerase regions during the adaptation to 0.05 mg/ml of AMD.
Anticodons were sorted in three groups based on the cellular anticodon usage: those used by the cell at a proportion above 60%, those used at a
proportion between 20 to 60% and those used at a proportion below 20%. The mean percent viral anticodon usage variation was calculated in the
mutant spectra with respect to the initial passage for each group of anticodons at each passage. Asterisks depict significant differences (p,0.05)
between the codon usage variation in a given passage with respect to the initial passage.
doi:10.1371/journal.ppat.1000797.g006
Translation Kinetics Selection in the HAV Capsid
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Also an increase in the 20%–60% group was detected, with
variations of the six main responsible anticodons (Ile: uaa, uau;
Leu: aac; Phe: aaa; Val: cag, cai) in lineage 1 of 4.92% and of the
ten main responsible anticodons (Ile: uaa, uau; Leu: aac; Phe: aaa;
Ser: aga, uca; Tyr: aua; Val: cag, cai, caa) in lineage 2 of 4.25%.
Although the population landscapes obtained with consensus
sequences are less representative than those obtained with the
molecular spectra, this is in some way compensated by the analysis
of a wider length and the results observed support the conclusions
from the molecular quasispecies analysis.
Moreover, during the process of adaptation to AMD, the RCDI
of the capsid coding region significantly (p,0.05) increased (Fig.
S3 and Table S1), indicating a re-deoptimization of the virus
codon usage under the new growing conditions.
Codon usage determines viral fitness in tRNA changing
conditions
To investigate whether codon usage plays a significant role on
viral fitness in conditions of depleted and abundant tRNA pools,
competition experiments between viral populations with codon
usages adapted to replicate in the absence or presence of AMD
were carried out. With this aim mixed populations at different
quantitative ratios were grown under different conditions (Fig. 8).
These experiments clearly demonstrated that lineage 1 (adapted to
grow in 0.05 mg/ml of AMD) was the fittest in the presence of
0.05 mg/ml of AMD and as early as after 4 passages completely
out-competed lineage 0 (adapted to grow in the absence of AMD)
when mixed at equal concentrations (Fig. 8A). In the most
quantitatively unfavorable condition, 12 passages were required to
out-compete lineage 0 (Fig. 8B). On the contrary, this latter
population was the fittest in the absence of the drug and clearly
out-competed the drug-adapted population after 6 and 12
passages, when mixed at equal concentrations (Fig. 8A) and in
quantitatively unfavorable condition (Fig. 8B), respectively.
In the presence of 0.2 mg/ml of AMD, lineage 2 (adapted to
grow in 0.2 mg/ml of AMD) clearly showed a better fitness and
rapidly out-competed lineage 1 (Fig. 8C) even in the most
unfavorable condition that required only 9 passages (Fig. 8D).
However, in the presence of 0.05 mg/ml of AMD, lineage 1 was
never able to out-compete lineage 2 and this latter lineage,
Figure 7. HAV anticodon usage variation in the capsid coding region during the adaptation to 0.2 mg/ml of AMD. Passage 65 of the
population adapted to 0.05 mg/ml of AMD was thereafter passaged in the presence of 0.2 mg/ml of the drug (lineage 2; right column). Left column
depicts the behavior of the population in the absence of AMD as baseline control. The percentage of variation of each individual viral anticodon in
the mutant spectra with respect to the cellular usage is shown. Mean and standard deviation of the variation of use of those anticodons with the
highest level of variation (encircled) is shown.
doi:10.1371/journal.ppat.1000797.g007
Translation Kinetics Selection in the HAV Capsid
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unable to totally out-compete lineage 1 when mixed at equal or
unfavorable ratio (Fig. 8C and 8D). This relative better fitness is
also evidenced by the incapacity of lineage 1 to affect lineage 2 in
0.05 mg/ml of AMD when the starting concentration of lineage 2
was highly favorable (Fig. 8D).
HAV capsid folding is independent on the activity of the
heat-shock protein 90 (Hsp90) chaperone
The effect of the Hsp90 chaperone inhibitor geldanamycin on
HAV production was investigated. HAV titers were not affected
by the presence of increasing concentrations of the drug ranging
from 0 to 1 mM. The estimated geldanamycin concentration
inducing a 50% virus titer reduction (IC50) was 5.370 mM (Fig. 9).
In contrast, PV titers were severely affected by the presence of the
drug, with an estimated IC50 of 0.275 mM. Since in the particular
case of PV, the decrease in titer is thought to be the result of an
impairment of capsid folding, which is dependent on the activity of
the Hsp90 [35], it can be assumed that HAV capsid folding is not
dependent on the activity of this specific chaperone and that it
should depend on other factors as might be the codon usage.
Discussion
Translation selection drives the optimal co-adaptation of the
codon usage and tRNA concentration, i.e. the most abundant
codons pair with the most abundant tRNAs, in order to get a
quantitatively highly efficient and accurate rate of translation [18].
In contrast, fine-tuning translation kinetics selection also presses
for a co-adaptation between codon usage and tRNA concentration
but in a different sense, i.e. the use of many different rare codons
pairing with non-abundant tRNAs, in order to get a locally slow
ribosome traffic rate to allow the proper protein folding [18]. The
codon usage of HAV is indeed highly biased and highly
deoptimized [23] with the highest RCDI value among picorna-
viruses, and thus translation selection does not seem to be the
evolutionary driving force of its codon bias. In such a situation the
viral translation rate is expected to be very slow, in agreement with
a highly inefficient IRES [28], since the rate of translation is
proportional to the concentration of charged tRNAs. We
attempted to adapt HAV to grow in an environment with a
higher tRNA availability through the specific inhibition of the
cellular protein synthesis with AMD, and to study the codon usage
Figure 8. Growth competition experiments. A and B. Populations adapted to grow in the absence of AMD (lineage 0) and in the presence of
0.05 mg/ml of AMD (lineage 1) were mixed at different ratios and grown in the absence of AMD or with 0.05 mg/ml of AMD. Initial population mixture
ratios were 1:1 (lineage 0: lineage 1) in A, and 100:1 (lineage 0: lineage 1) and 1:100 (lineage 0: lineage 1) in B. C and D. Populations adapted to grow
with 0.05 mg/ml (lineage 1) and 0.2 mg/ml of AMD (lineage 2) were mixed at different ratios and grown in the presence of 0.05 mg/ml of AMD or with
0.2 mg/ml of AMD. Initial population mixture ratios were 1:1 (lineage 1: lineage 2) in C, and 100:1 (lineage 1: lineage 2) and 1:100 (lineage 1: lineage 2)
in D.
doi:10.1371/journal.ppat.1000797.g008
Translation Kinetics Selection in the HAV Capsid
PLoS Pathogens | www.plospathogens.org 8 March 2010 | Volume 6 | Issue 3 | e1000797re-adaptation, if any, to these new conditions. Although our initial
hypothesis was that an environment of increased tRNA availability
would result in an improvement of HAV viral translation rate,
what we found during the first passages of the virus in the presence
of AMD was a significant decrease of the infectious viral
production per cell (Fig. 2). Nevertheless, the most striking finding
was that further on (over 40 passages) a fitness recovery was
observed (Fig. 4), in both the population adapting from 0 to
0.05 mg/ml (lineage 1) and the population adapting from 0.05 to
0.2 mg/ml of AMD (lineage 2). In contrast, PV did not suffer a
decrease in fitness during the process of adaptation to AMD and
rather experienced a significant increase of virus production per
cell when growing in the presence of 0.2 mg/ml of AMD (Fig. 3).
However, PV follows a completely different strategy with a highly
optimized codon usage to that of the cell and thus confirming that
viral production is at its best when there is a good match between
codon usage (demand) and tRNA availability (supply).
The analysis of the HAV codon usage adaptation to AMD
revealed an interesting adjustment in the capsid region. If
translation selection is the driving force of the codon usage, a
tendency to optimize the codon usage should be expected. Instead
what was detected was a re-deoptimization getting to an increased
use of those uncommon tRNAs. This re-deoptimization was
associated with a fitness recovery in terms of infectious virus
production, suggesting that the loss of efficiency in translation
would be compensated by a different capsid folding, affecting
stability and/or exposure of the receptor binding site. Preliminary
data point to a change in the antigenic structure and thermal
stability of the viral capsid during the adaptation to AMD (data
not shown). Further proteomic analyses to confirm these
hypotheses are in progress, but the genomic studies provide
evidence suggesting that fine-tuning translation selection is actually
contributing to the codon usage bias of HAV. Additional selective
pressures may derive from the decrease of some cellular factors
required for HAV replication and translation in conditions of
cellular shut-off. Virus adjustment to this new situation may be
mediated by mutations inducing changes in the RNA structure.
However, it is unlikely that these mutations result in a change in
RNA structure concomitant with a change in codon usage. Other
alternative interpretations include AMD-associated alterations of
3D, 3C or 3CD activities although fitness recovery was not
associated with mutations in these regions.
Fine-tuning translation of the capsid is graphically evidenced
during the back adaptation process of viral lineage 3, from
0.05 mg/ml to 0.0 mg/ml of AMD (Fig. S2), where the population
seeks a kind of dynamic equilibrium regarding the variation in the
anticodon usage. Most rare codons in the capsid coding region are
rare codons pairing with abundant tRNAs, while only a few of
them are rare codons pairing with rare tRNAs. Many of these rare
codons pairing with abundant tRNAs (62%) were replaced during
the process of adaptation to AMD, all of them to codons pairing
with less abundant tRNAs, while those more common codons
pairing with non-abundant tRNAs were replaced at a lower
frequency (34%), and most of them to codons pairing with even
less common tRNAs (Table S2). Most HAV capsid residues coded
by rare codons are strategically located in the carboxy terminal
regions of the putative highly structured elements [23]. A higher
tendency of replacement of these strategically located rare codons
in comparison with those located apart from these regions was
observed (Table S3), indicating the potential relevance of the
translation kinetics in providing locally slow ribosome traffic rates
and thus contributing to the proper capsid protein folding.
Actually, it is interesting that whereas the capsid folding of many
picornaviruses is dependent on the activity of the heat-shock
protein 90 (Hsp90) chaperone [35], that of HAV is not (Fig. 9).
Additionally, the fact that substitutions detected in the 3D region
during the adaptation to AMD do not tend to re-deoptimize the
codon usage as occurs in the capsid region (Fig. 6) together with a
significantly lower mutation rate in the 59 NCR of the population
adapting to the drug (data not shown), which are not under the
pressure of the translational machinery, re-enforces the critical role
of translation kinetics in the capsid region.
Selection for fine-tuning translation kinetics in the HAV capsid
acts on the whole virus population and the flattest population
(mutant spectrum) rather than the fittest individual is selected. In
fact, a blend of mutations occurring around the swarm of genomes
affecting the overall codon usage was associated with fitness
recovery. The critical role of the mutant spectra is also observed in
the faster adaptation of the populations during the back processes
from higher to lower and from presence to absence of AMD than
during the forward processes, pointing to the existence of
molecular memory in the quasispecies as described elsewhere [36].
Codon usage adaptation to tRNA availability must find a
critical balance between the rate of translation and the proper
protein folding to reach the highest fitness. While, generally, the
viral populations adapted to a given tRNA pool, out-competed the
non-adapted populations under those specific conditions (Fig. 8),
the exception to the rule was the particular case of lineage 2
(adapted to grow in 0.2 mg/ml of AMD) in competition
Figure 9. Relative infectious virus production per cell of HAV
and PV in the presence of increasing concentrations of
geldanamycin, a heat-shock protein 90 (Hsp90) inhibitor. Viral
production at each geldanamycin concentration is expressed as a
percentage of viral production in the absence of the drug.
doi:10.1371/journal.ppat.1000797.g009
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AMD) in the presence of 0.05 mg/ml of AMD. Under these
conditions, the populations were unable to out-compete each
other, suggesting some kind of cooperation rather than competi-
tion (Fig. 8 C and D). Although difficult to predict, it may be
hypothesized that the expected slower translation rate of lineage 2
might be compensated with a higher quality capsid-folding and
that the faster translation rate of lineage 1 might provide a higher
level of the viral enzymes required for RNA replication and capsid
maturation. Experiments are, presently, in progress to assess this
point.
HAV behavior in terms of mutation-selection for a fine-tuning
translation kinetics allowed for fitness recovery but not fitness gain
during the different processes of adaptation to the cellular tRNA
changing conditions and thus it may represent an additional view
of the Red Queen dynamics of protein translation [37]. At least
from the viral side it is clear that in a hostile environment ‘‘it takes
all the running you can do to keep in the same place’’.
Evolutionary adaptive changes are required to maintain fitness
and cessation of change may result in extinction.
Materials and Methods
Cells and viruses
The cytopathogenic pHM175 43c strain of HAV was used for
the study of HAV replication and evolution in the presence of
actinomycin D (AMD, Sigma). Serial passages in 0.0 mg/ml
(lineage 0), 0.05 mg/ml (lineage 1) and 0.2 mg/ml (lineage 2) of
AMD were carried out with a multiplicity of infection (m.o.i.) of 1,
at a 7-day interval. Additionally, pre-adapted populations were
returned to the original conditions from 0.05 mg/ml to 0.0 mg/ml
of AMD (lineage 3) and from 0.2 mg/ml to 0.05 mg/ml of AMD
(lineage 4). The LSc 2ab strain of poliovirus was also grown in the
absence or presence of AMD and passaged every 2 days at a m.o.i.
of 1. The infectious virus titer (TCID50) was obtained for both
viruses in FRhK-4 cell monolayers. Virus yield per cell was figured
taking in consideration the average cell viability under each
condition (between days 4 and 7, and at day 2, for HAV and PV,
respectively). HAV and PV production in the presence of
geldadamycin concentrations from 0.062 to 1 mM was evaluated
in the same way.
Actinomycin D-induced cellular shut-off
AMD-associated cytotoxicity was measured by counting viable
cells using the trypan blue exclusion method. Total cytoplasmic
RNA abundance from 10
6 cells treated with 0.2 mg/ml, 0.05 mg/
ml or 0.0 mg/ml of AMD, and from untreated cells infected with
HAV was quantified using the NanoDropH ND-1000 spectropho-
tometer, as a measure of the cellular genome expression.
Additionally the expression level of two cellular genes, HPRT-I
(hypoxanthine phosphoribosyl-transferase I) and GAPDH (glycer-
aldehide-3-phosphate dehydrogenase) [38,39], was also monitored
by end-point dilution RT-PCR using previously described primers
[40,41] for all aforementioned conditions.
Quasispecies analysis
Two genomic regions of the capsid coding region were
analyzed: a fragment of the VP3-coding region, corresponding
to amino acids 1–123, and a fragment within the VP1-coding
region, corresponding to amino acids 85–245. Besides, another
fragment corresponding to amino acids 1–253 of the nonstructural
protein 3D (polymerase), was also analyzed. RT-PCR amplifica-
tion of the specified RNA fragments was performed as described
elsewhere [33]. Previously described primers [33] were used for
the amplification of the VP3 and VP1 fragments, while for the 3D-
fragment primers 3D- (59ATGATTCTACCTGCTTCTCT39)
and 3CD (59ATTGGGATCCAAGAAAATTGAAAGTCA39)
were designed. PCR products were cloned and the sequence from
50 molecular clones obtained as previously described [33].
Genomic analysis
Viral codon usage tables were obtained for each viral
population at several passages through the analysis of the
sequences of 50 molecular clones. Two codon usage tables were
made, one using the sequences of the VP1- and VP3-fragments as
a model for the structural proteins coding region and another
using the sequences of the 3D-region as a model for the non-
structural proteins coding region. Anticodon usage tables were
inferred from these codon usage tables by assuming a model based
on the frequency of the codons, the anticodon degeneracy and the
codon:anticodon match pairing preferences [19] (Tables S4 and
S5). Additionally, an anticodon usage table was also drawn for the
host cell (Tables S4 and S5) and anticodons sorted in those used
less than 20%, those used between 20 and 60% and those used
more than 60%. The relative variation of usage of each anticodon
at each viral passage compared to the initial passage was
calculated. The mean variation of the viral anticodons belonging
to each of the previously defined groups was calculated and
significant differences between the mean variations in the
populations growing in the absence or presence of the drug
analyzed by a T-student test.
Growth competition experiments
Growth competition experiments between viral lineages 0 and 1
were performed after mixing the populations at ratios of 1:1, 100:1
and 1:100 and grown in the absence or presence of 0.05 mg/ml of
AMD. Additionally, competition experiments between lineages 1
and 2 at ratios 1:1, 100:1 and 1:100, and grown in the presence of
0.05 mg/ml and 0.2 mg/ml of AMD were also performed. A m.o.i.
of 1 was used, with the exception of those experiments in which
the mixing ratios were 1:1 in which the m.o.i. was 2. Viral progeny
of each competition experiment was passaged several times and
consensus sequences obtained.
To follow up the proportion of each population several genetic
markers were used: two mutations that were present in the
consensus sequence of lineage 1 and absent in lineage 0 (aRga t
nucleotide 2459 and aRg at nucleotide 2643), and two additional
mutations only present in lineage 2 (cRu at position 1282 and
cRu at nucleotide 1393). These latter mutations occurred in the
VP0 coding region which was sequenced using previously
described primers [42]. These specific genetic markers allowed a
semiquantitative monitoring of the populations through determi-
nation of the proportional height of the two peaks at each
nucleotide position inferred from the chromatogram of the
consensus sequences.
Supporting Information
Table S1 Relative codon deoptimization indexes (RCDI) of
different picornaviruses were calculated from the complete
genome sequences available at the GenBank. The RCDI of the
mutant spectra of the pHM175 43c strain of HAV growing in the
absence or in the presence of 0.05 mg/ml and 0.2 mg/ml of AMD
was also assessed.
Found at: doi:10.1371/journal.ppat.1000797.s001 (0.01 MB PDF)
Table S2 Number and percentage of codons replaced in the
capsid region during both the process of adaptation to increasing
concentrations of actinomycin D (passages P4, P5, P20, P36, P38,
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were analyzed) and the re-adaptation to the absence of
actinomycin D (passage P21 of lineage 3 was analyzed). The
repetitions observed in different passages were not quantified.
Codons were sorted between rare and common, being the rare
codons those pairing with abundant tRNAs and the common
codons those pairing with less abundant tRNAs. Those rare
codons pairing with rare tRNAs were excluded of the analysis. As
a control the substitutions detected in the population growing in
the absence of the drug were also included (passages P4, P5, P20,
P36, P38, P41, P44, P65 and P85 of lineage 1 were analyzed).
Found at: doi:10.1371/journal.ppat.1000797.s002 (0.01 MB PDF)
Table S3 Location of the rare codons pairing with abundant
tRNAs in the VP3 and VP1 regions analyzed. The protein
fragments were divided in two regions, the carboxy-ends and
borders of the highly structured elements (b-barrels and a-helices)
and the remaining part of the protein, following previously
published criteria [23]. The so-called carboxy-limits were defined
as the third carboxy-part of the structural elements plus the 5
contiguous external residues. In some instances, when the b-
barrels or the a-helices were shorter than 3 residues, only one
internal residue was included; when the length of the external
joining residues was shorter than 5 before entering the next
structural element, the totality of the joining region was included.
Found at: doi:10.1371/journal.ppat.1000797.s003 (0.01 MB PDF)
Table S4 Conversion from codon usage tables to anticodon
usage variation in the capsid regions studied. A) Codon counts in
50 molecular clones of the different populations studied. B)
Anticodon usage estimation from the codon counts, applying the
multiple codon:anticodon pairing and the codon:anticodon
coupling efficiencies described elsewhere [2]. C) Usage of each
anticodon (in percentage) out of the total usage of the anticodons
bearing the same aminoacid. D) Variation (increasing or
decreaing) of the relative usage of each anticodon from the initial
passage.
Found at: doi:10.1371/journal.ppat.1000797.s004 (0.05 MB PDF)
Table S5 Conversion from codon usage tables to anticodon
usage variation in the polymerase region studied. A) Codon counts
in 50 molecular clones of the different populations studied. B)
Anticodon usage estimation from the codon counts, applying the
multiple codon:anticodon pairing and the codon:anticodon
coupling efficiencies described elsewhere [19]. C) Usage of each
anticodon (in percentage) out of the total usage of the anticodons
bearing the same aminoacid. D) Variation (increasing or
decreaing) of the relative usage of each anticodon from the initial
passage.
Found at: doi:10.1371/journal.ppat.1000797.s005 (0.03 MB PDF)
Figure S1 Infectious HAV titer production per cell during the
first 20 adaptation passages of lineages 1 (adaptation to 0.05 mg/
ml of AMD) and 3 (adaptation from 0.05 mg/ml to 0.0 mg/ml of
AMD), and lineages 2 (adaptation from 0.05 mg/ml to 0.2 mg/ml
of AMD) and 4 (adaptation from 0.2 mg/ml to 0.05 mg/ml of
AMD). Linear regression analysis showed that the kinetics of
adaptation were faster (with significant differences in the slopes,
p,0.05) in the re-adaptation to the original conditions than in the
first adaptation to the different AMD concentrations.
Found at: doi:10.1371/journal.ppat.1000797.s006 (0.99 MB TIF)
Figure S2 Re-adaptation from 0.05 to 0.0 mg/ml of AMD.
Right panel depicts the behavior of the population re-adapting
from 0.05 to 0.0 mg/ml of AMD (lineage 3). Left panel depicts the
behavior of the population in 0.05 mg/ml of AMD as baseline
control. The percentage of variation of each individual viral
anticodon in the mutant spectra with respect to the cellular usage
is shown. Mean and standard deviation of those anticodons with
the highest level of variation (encircled) is shown.
Found at: doi:10.1371/journal.ppat.1000797.s007 (0.58 MB TIF)
Figure S3 Relative codon deoptimization index (RCDI) during
the process of adaptation to AMD. A. RCDI (mean6SD) in the
capsid coding region. B. RCDI (mean6SD) in the polymerase
coding region. During the process of adaptation to 0.05 m g/ml of
AMD no differences were detected until P44 (hence two values are
given). The first value represents passages P1-P44 and the second
passages P45–P103. As it can be observed, the capsid region
showed a significant increase of the RCDI during the process of
adaptation to increasing AMD concentrations. On the contrary,
the RCDI of the polymerase coding region although showing a
tendency to decrease did not significantly vary.
Found at: doi:10.1371/journal.ppat.1000797.s008 (0.49 MB TIF)
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